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Abstract 
 
The present study was conducted to detect prevalence and risk factors for retrovirus 
infection of infected cats in a cat population in Iran, by evaluation of 238 client-owned 
cats of different ages that were tested for the presence of FIV antibodies. The cats were 
selected from those referring to Veterinary Hospital of Ahvaz University, southwestern 
Iran  from December 2007 to June  2010.  Classification was made by age, sex, breed, 
region and season. The studied cats were divided into two age groups ( ≤ 3 years and >3 
years) and based on clinical signs into two groups. Prevalence of FIV antibodies in these 
cats was 10.5 % by immunochromatography assay, indicating that this virus is present in 
the  environment.  The infection had more prevalence in cats above 3 years (13.9  %) 
compared with cats less than 3 years (4.6  %). Statistical analysis showed significant 
difference between different age groups. Mean age of FIV-infected and FIV-negative cats 
were 4.93 ± 0.43 years (range 1.75 – 10 years) and 4.15 ± 0.20 years (range 0.4 – 15 
years), respectively. Prevalence of infection was 12.6% in males and 8.1 % in females; 
nevertheless the infection was not significant between different sexes (P > 0.05). Six out 
of 36 cases (16.7 %) which had clinical signs and 19 out of 202 cases (9.4 %) which  did 
not have  clinical signs were seropositive, without significant difference between two 
groups (95 % CI for OR = 1.92). Risk factors for FIV infection were older age (95 % CI 
for OR = 3.35), access to outdoor (95 % CI for OR = 140.9) and aggressive behavior (95 
% CI for OR = 82.71).  
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Introduction 
 
Feline immunodeficiency virus (FIV) is a 
retrovirus of the genus lentivirus that is 
closely related to human 
immunodeficiency virus  (HIV), sharing a 
similar structure, life cycle and 
pathogenesis.
1  FIV is an important viral 
pathogen worldwide in cats and differs 
from  feline leukemia virus  (FeLV) and 
feline foamy virus  (FFV). Five different 
subtypes have been recognized for FIV 
(subtypes A, B, C, D, and E).
2-4 In natural 
settings, FIV is transmitted primarily by 
parenteral inoculation of virus present in 
saliva or blood, presumably by bite and 
fight wounds, accounting for the higher 
prevalence in male cats.
5 Clinical signs are 
generally manifest in middle age cats (4-7 
years) that have harbored the virus for an 
extended period, but cats of any age may 
contract the disease. These signs may 
include chronic gingivitis, periodontal 
disease, chronic anemias and leukopenias, 
pustular dermatopathies, chronic upper 
respiratory syndrome and generalized 
lymphadenopathy.
4,6  The seroprevalence 
of FIV is highly variable between regions, 
with estimates of 1–14 % in cats with no 
clinical signs and up to 44 % in sick cats.
7 
Since its discovery in 1987 many studies 
have been conducted worldwide to 
determine the distribution of FIV.
8 
Reported prevalence differs considerably 
depending on the geographical region and 
the cat population evaluated. In Asian 
surveys the prevalence varies from 0 % to 
22  %.
9,10  In North America, the most 
recent study reports a prevalence of FIV 
infection of 2.5 % in client-owned cats
11 
and between 3.5  % and 23  % in  stray 
cats.
12,13  Approximately 10  % of cats in 
Southern Europe are infected with FIV. 
14,15  Whereas Northern European studies 
report prevalences of 2–6 %.
7,16  A large 
number of different approaches have been 
taken in attempts to create FIV vaccines.
17 
Rapid diagnosis of FIV infection is 
especially important in order to isolate 
infected cats and prevent secondary 
infections of susceptible animals. In Iran, 
large numbers of cats are found roaming 
residential streets. They can be an 
important potential source of transition of 
infection to other animals. Several 
laboratory methods have been developed 
to detect antigen or antibody in the serum 
of infected cats such as PCR, ELISA, LAT 
(latex agglutination test), IHA  (Indirect 
hemagglutination assay
  ), VN  (Virus 
neutralization)  and IFAT  (Indirect 
Fluorescent Antibody Test). Though these 
tests are more sensitive, specific and more 
reproducible, but they can be expensive 
and generally take time to be analyzed by 
a specialized laboratory. 
Immunochromatography  assay (ICA)
7  is 
one of the most common rapid field 
diagnostic methods used in clinical 
practice. Specificity and sensitivity for kits 
of FIV Ab Test (Biotech Co., Ltd, 
Shanghai) were found to be above 95 
percent according to the manufacture. The 
aim of this study was first to investigate 
the antibody detection of FIV in the serum 
samples of client-owned cats in Ahvaz 
area, southwestern Iran. Secondly, risk 
factors were evaluated for FIV infection. 
This survey provides preliminary 
information regarding FIV endemic to the 
Ahvaz region.  
Materials and Methods 
 
Sample collection and preparation. 
Blood samples were randomly collected of 
238 companion cats from December 2007 
to June 2010, in Ahvaz area, the capital of 
Khouzestan province in southwestern Iran. 
The samples were collected from jugular 
veins and allowed to clot and centrifuged 
for 5 min at 1800× g. Serum was removed 
and stored at −20°C until assayed.  The 
studied cats were divided into two age 
groups (≤ 3 years and > 3 years) and based 
on clinical signs (such as 
lymphadenopathy, periodontal diseases, 
gingivitis, abscess and cachexia) into two 
groups.  Investigated parameters included 
putative risk factors including age, gender B. Mosallanejad et al / Veterinary Research Forum. 3(Dec., 2010) 180 - 187 
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and breed. All cats were grouped with 
regard to housing conditions (only indoors 
or outdoors; single or multi-cat household; 
contact or no contact with other cats) and 
with regard to fighting behavior (fighting 
or not fighting). One hundred and twenty 
seven male and 111 female cats were 
studied. Two ml blood was collected from 
jugular vein of cats to determine CBC. 
Ketamine (10 mg kg
-1) and acepromazine 
(0.15 mg kg
-1) were injected for sedative 
effects. The age of the cats ranged between 
0.4 to 15 years. Age was estimated by 
dental formulary and owner information's. 
Owners were asked to fill  out a 
questionnaire for further information about 
signalment of tested cats.  Most of the 
studied cats (191) were Domestic Short 
Hair (DSH), 28 Persian cats and 19 long 
hair cats.  
Laboratory methods.  The test was 
carried out with a commercial rapid FIV 
Ab test kit (Manufactured by Biotech Co., 
Ltd, Shanghai, Catalog No. W81042) 
according to  the manufacturer's 
instructions. The kit is a chromatographic 
immunoassay for the qualitative detection 
of FIV  antibody in feline serum. 
Immunochromatographic  tests are  based 
on immune-complex formation of antigen 
with antibody. All data were entered and 
stored in a computerized database.  
Interpretation of the test.  We added 
four drops of the serum sample into the 
holes using the dropper, drop by drop and 
slowly. As the test began to work, we saw 
purple color move across the result 
window in the center of the test device. A 
color band will appear in the left section of 
the result window to show that the test is 
working properly. This band is the control 
band. The right section of the result 
window indicates the test results. If 
another color band appears in the right 
section of the result window, this band is 
the test band. The presence of only one 
band within the result window indicates a 
negative result. The presence of two color 
bands (T and C) within the result window, 
no matter which band appears first, 
indicates a positive result. Finally, test 
results were interpreted at 5 - 10 minutes 
(according to the manufacturer’s 
instructions). 
Statistical analysis.  Test results and 
potential association with age, sex, breed, 
risk factors, CBC and clinical signs were 
performed with standard software (SPSS 
15.0 for Windows, SPSS, Chicago, 
Illinois, USA) by Fishers exact test, Chi-
square test, Independent sample t-test and 
Logistic regression. Values of P  ≤  0.05 
were considered to indicate a statistically 
significant difference.  
 
Results 
 
Prevalence and risk factors. Prevalence 
to FIV antibodies in these cats was 10.5% 
(25 out of 238) by ICA, indicating that this 
virus is present in the ecosystem. The 
infection had more prevalence in cats 
above 3 years (13.9  %; 21 out of 151) 
compared with cats less than 3 years (4.6 
%; 4 out of 87) and odds ratio was 3.35 
(95  % CI 1.11-10.11). The age of FIV-
positive pet cats ranged from 1.75 to 10 
years. The mean age of FIV-infected and 
FIV-negative cats were 4.93 ± 0.43 years 
(range 1.75 – 10 years) and 4.15 ± 0.20 
years (range 0.4 – 15 years), respectively. 
Six out of 36 cases (16.7 %) which had 
clinical signs and 19 out of 202 cases (9.4 
%) which hadn’t clinical signs were 
seropositive, without significant difference 
between two groups (95 % CI for OR = 
1.92). Prevalence of infection was 12.6 % 
(16 out of 127) in males and 8.1 % (9 out 
of 111) in females,  nevertheless the 
infection was not significant between 
different sexes (P  >  0.05). Leukopenia 
(less than 5500 cells/ml), lymphopenia 
and neutropenia were seen in most of the 
affected cats to infection (72 %; 18 of 25). 
The difference was significant for 
leukopenia (P < 0.05). Regression analysis 
confirmed several factors included older 
age (95 % CI for OR = 3.35), access to 
outdoor and contact to other cats (95 % CI 
for OR = 140.9) and aggressive behavior  B. Mosallanejad et al / Veterinary Research Forum. 3(Dec., 2010) 180 - 187 
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Table 1. Prevalence of Feline immunodeficiency virus infection in cats with different age and sex in 
Ahvaz district, Iran by ICA Kits, 2007-2010. 
 
Age         ≤ 3 years      > 3 years 
Sex  Neg.  Pos.  Neg.  Pos. 
Male  38  2  73  14 
Female  45  2  57  7 
Total = 238  83  4  130  21 
 
 
(95 % CI for OR = 82.71) that were 
significantly associated with risk of FIV 
infection. Living in a multi-cat household 
did not influence the risk of FIV infection. 
Twenty two out of 191 DSH cats and 3 out 
of Long hair cats were seropositive 
without significant difference (P > 0.05). 
Results are summarized in Table 1. 
 
Discussion 
 
The present study is the first report on the 
prevalence of Feline  immunodeficiency 
virus in companion cats in Ahvaz district, 
South-West of Iran, using ICA kits, 
revealed that 10.50  % of cats were 
seropositive for FIV. The results indicated 
that FIV can be as a cause of mortality in 
cat’s population in this area. Antibody 
detection against FIV is very important in 
cat population, because FIV is highly 
contagious and there are many stray cats in 
this area. These animals can be concerned 
in disease transmission to other cats, 
particularly companion cats. The first 
study on FIV in Iran was carried out by 
Malmasi (2002) in Tehran, Iran.
18 Two out 
of 131 samples were positive against FIV 
by western blot technique. Akhtardanesh 
et al. (2010) showed 19.2 % infections in 
cat's population in Kerman, Iran by ICA.
19  
FIV is a common feline pathogen; with 
an overall infection prevalence of 
approximately 11 % in cats' worldwide.
20 
Depending on the design, the sample 
population and the laboratory 
methodology implemented, prevalence has 
been found to vary considerably between 
studies.  Some countries report few 
infected cats, and others, such as Italy and 
Japan, with large populations of free-
roaming cats have prevalence rates that 
can approach 30  %.
21  Seroprevalence of 
FIV infection was reported 3.6 % from the 
Gulf Coast hurricane disaster area,
22 8.8 % 
in feral cats on Mauna Kea, Hawaii,
23 5.3 
% in Germany by Adler et al. (2007),
24 8 
% in the pet cat sample population in 
Sydney Australia,
25 8.8 % of the samples 
tested in Costa Rica,
26 0 % in Galapagos,
27 
11.3  % in the district of Pisa, central 
Italy,
15 7.4 % in Spain,
28 23 % in the urban 
strays, 5 in the feral cat colony, and 5.9 in 
the client-owned cats of Ottawa,
13  in 6 
domestic and 22 feral cats in west India,
29 
2.3 % in North America,
11 0-6 in central 
west Saudi Arabia,
30  3.2 in Germany  by 
Gleich  et al. (2009),
31  25  % in wild 
Mongolian Pallas' cats 
32  and 4.3 among 
cats in Canada.
33  
Cats between 4–7 years old are in 
increased risk.
4  FIV was significantly 
higher in adult cats than in juveniles and in 
males than in females.
22  88.8  % of the 
seropositive cats were older than 1 year of 
age, and a greater proportion of 
seropositive males (66.6 %) was found.
26 
The median age of FIV-positive pet cats 
(11 years) was significantly greater than 
the median age of FIV-negative pet cats. 
Median age was 6 years for FIV in 
Germany. Risk factors for FIV infection 
were male gender, older age, mixed breed, 
access to outdoor, aggressive behavior, 
and FeLV co-infection.
31 Cats with higher 
age have more contact with infected 
animals. Male cats are affected to FIV 
more than females due to more contention B. Mosallanejad et al / Veterinary Research Forum. 3(Dec., 2010) 180 - 187 
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between males, but our studies could not 
demonstrate a correlation between gender 
and disease. These results were similar to 
work of Levy et al. (2006)
11, however in 
contrast to Gleich et al. (2009) in 
Germany.
31 
In stray cat's population, both sexes are 
similarly exhibiting the infection, although 
male cats were at higher risk for FIV as 
reported by Luria et al. (2004).
34 Our study 
showed that the seroprevalence of 
infection was more in cats above 3 years 
(13.9 %) compared with cats less than 3 
years (4.6  %), and the difference was 
significant by statistical analysis (P  < 
0.05). Cats may sero-convert in as short as 
3 weeks or as long as 10 months after 
becoming infected with FIV. Also, care 
must be taken when interpreting test 
results in kittens less than four months of 
age as maternal FIV antibodies may be 
present. So cats selected in our study were 
above 1 year. 
As ten out of 14 ill cats had leucopenia, it 
seemed that leukopenia was an important 
paraclinical  feature  in cats suspicious  of 
FIV.  Complete blood count is useful, 
particularly in concurrent infections. 
Hematological abnormalities were 
detected in 48  % of FIV-infected 
asymptomatic cats in which no other cause 
of cytopenia than FIV infection was 
observed. Anemia only, neutropenia only, 
thrombocytopenia only, bicytopenia and 
pancytopenia were observed in 10 %, 10 
%, 6 %, 14 % and 8  %, respectively by 
Fujino  et al. (2009).
35  leukopenia  (less 
than 5500 cells/ml), lymphopenia and 
neutropenia  were seen in most of the 
affected cats to infection (72 %). 
Infection with opportunistic pathogens of 
viral, bacterial, protozoal, and fungal 
origin have been reported in FlV-infected 
cats.
4,36-40  In  a  report  by  Dubey  et al. 
(2009),  there was no correlation among 
Toxoplasma  gondii,  Bartonella spp., and 
FIV seropositivity.
29  Infection with either 
FeLV or FIV was associated with  an 
increased risk for coinfection with the 
other retrovirus, M. haemofelis, or M. 
haemominutum.
34  
Our data indicated that chronically 
infected carriers without clinical 
symptoms  were  frequent in the 
investigated cat population. Among the 
FIV positive cats, 16.7 % of the cats with 
clinical signs  were seropositive, whereas 
9.4  %  of the cats without clinical signs 
were seropositive for FIV. These findings 
show that clinical signs are not significant 
for definitive diagnosis of FIV. In 
conclusion, we emphasis that prevention 
of contact with stray cats could be an 
important  measure  in the control of FIV 
infections  to  companion cats. 
Unfortunately, vaccination against FIV is 
not present in Iran and many countries. 
Whether vaccination will reduce or 
increase the incidence of infection in the 
cat population at large is unknown.
20 
Further epidemiological and biological 
surveillance are needed to control the 
disease in stray and domestic cats.  
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